Status:

COMPLETED

Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

Lead Sponsor:

Annexon, Inc.

Conditions:

Guillain-Barre Syndrome

Eligibility:

All Genders

16+ years

Phase:

PHASE3

Brief Summary

This study is intended to evaluate the efficacy and safety of ANX005 administered by intravenous (IV) infusion to participants recently diagnosed with Guillain-Barré Syndrome (GBS). The total duration...

Eligibility Criteria

Inclusion

  • Diagnosis of GBS according to the National Institute of Neurological Disorders and Stroke Diagnostic Criteria for Guillain-Barré Syndrome.
  • Onset of GBS-related weakness ≤10 days prior to start of infusion.
  • GBS-DS score of 3,4, or 5 at screening and at Day 1 prior to infusion.

Exclusion

  • Clinically significant findings on the screening electrocardiogram (ECG), laboratory test results, or physical examination that are not specific to GBS that may interfere with the conduct of the study, the interpretation of the data, or increase the participant's risk.
  • Body weight \<30 kilograms (kg) or \>150 kg at screening.
  • Unresponsive (inexcitable) nerve conduction study results in all nerves tested during screening.
  • Previous or intended treatment with either plasma exchange or intravenous immunoglobulin for GBS.
  • Diagnosis of a variant of GBS, including Miller Fisher syndrome, Bickerstaff's encephalitis, and overlap syndromes.
  • History of prior episode of GBS.
  • GBS-related weakness that improved since symptom onset, including an improvement between screening and Day 1 (baseline).

Key Trial Info

Start Date :

December 17 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 20 2024

Estimated Enrollment :

242 Patients enrolled

Trial Details

Trial ID

NCT04701164

Start Date

December 17 2020

End Date

April 20 2024

Last Update

May 29 2025

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Dhaka Medical Center

Dhaka, Bangladesh

2

National Institute of Neurosciences and Hospital (NINS)

Dhaka, Bangladesh

3

Baguio General Hospital Medical Center

Baguio City, Philippines

4

Batangas Medical Center

Batangas, Philippines